Varian Medical Systems, Inc.  

(Public, NYSE:VAR)   Watch this stock  
Find more results for VAR
69.88
+0.43 (0.62%)
May 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 69.57 - 70.44
52 week 52.90 - 75.78
Open 69.64
Vol / Avg. 542,185.00/989,877.00
Mkt cap 7.62B
P/E 17.84
Div/yield     -
EPS 3.92
Shares 109.11M
Beta 0.86
Inst. own 93%
Jul 24, 2013
Q3 2013 Varian Medical Systems, Inc. Earnings Conference Call - 5:00PM EDT - Add to calendar
Jun 3, 2013
Varian Medical Systems, Inc. at Jefferies Global Healthcare Conference Add to calendar
Apr 24, 2013
Q2 2013 Varian Medical Systems, Inc. Earnings Conference Call
Feb 26, 2013
Varian Medical Systems, Inc. at Citi Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 14.68% 15.21%
Operating margin 20.26% 21.16%
EBITD margin - 23.34%
Return on average assets 15.08% 15.88%
Return on average equity 28.24% 31.02%
Employees 6,100 -
Carbon Disclosure Rating - 81/100

Address

3100 Hansen Way
PALO ALTO, CA 94304-1030
United States - Map
+1-650-4934000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Varian Medical Systems, Inc. is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and brachytherapy. The Company also designs, manufactures, sells and services x-ray tubes for original equipment manufacturers (OEMs); replacement x-ray tubes, and flat panel digital image detectors for filmless x-ray imaging (flat panel detectors or digital image detectors) in medical, dental, veterinary, scientific and industrial applications. It designs, manufactures, sells and services linear accelerators, digital image detectors, image processing software and image detection products for security and inspection purposes. In March 2011, it acquired a privately-held supplier of devices for delivery of brachytherapy treatment of cancer. In August 2012, the Company established a subsidiary, Varian Medical Systems Korea.

Officers and directors

Richard M. Levy Ph.D. Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Dow R. Wilson President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Elisha W. Finney Chief Financial Officer, Corporate Executive Vice President - Finance
Age: 51
Bio & Compensation  - Reuters
Clarence R. Verhoef Corporate Senior Vice President - Finance, Corporate Controller
Age: 57
Bio & Compensation  - Reuters
John W. Kuo Corporate Senior Vice President, General Counsel, Corporate Secretary
Portrait. Age: 49
Bio & Compensation  - Reuters
Kolleen T. Kennedy Corporate Senior Vice President, President - Oncology Systems
Age: 53
Bio & Compensation  - Reuters
Robert H. Kluge Corporate Senior Vice President, President - X-ray Products
Age: 66
Bio & Compensation  - Reuters
R. Andrew Eckert Lead Independent Director
Age: 51
Bio & Compensation  - Reuters
Susan L. Bostrom Independent Director
Age: 52
Bio & Compensation  - Reuters
David J. Illingworth Independent Director
Age: 59
Bio & Compensation  - Reuters